LACK-specific CD4+ T cells that induce gamma interferon production in patients with localized cutaneous leishmaniasis during an early stage of infection

被引:22
作者
Bourreau, E
Prévot, G
Gardon, J
Pradinaud, R
Hasagewa, H
Milon, G
Launois, P
机构
[1] Inst Pasteur, Serv Epidemiol, Cayenne 97306, French Guiana
[2] Ctr Hosp Andree Rosemon, Inst Guyanais Dermatol Trop, Cayenne 97300, French Guiana
[3] Ehime Univ, Sch Med, Shigenobu, Ehime 79102, Japan
[4] Inst Pasteur, F-75024 Paris 15, France
关键词
D O I
10.1128/IAI.70.6.3122-3129.2002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The profile of cytokines induced by soluble leishmania antigen (SLA) and the Leishmania homologue of the mammalian receptor for activated C kinase (LACK), a candidate vaccine against leishmaniasis, and the cellular source of the cytokines produced in response to these antigens were analyzed in patients infected with Leishmania guyanensis. Gamma interferon (IFN-gamma) and interleukin-10 (IL-10) were produced in response to LACK. Although LACK-specific CD4(+) cells producing IFN-gamma were isolated only during the early phase of infection (less than 30 days following the onset of infection), cells producing IL-10 in response to LACK were detected in all patients. CD4(+) T cells producing IFN-gamma and IL-13 were produced in response to SLA in all patients. SLA- and LACK-specific T cells are effector memory cells, as they are CD45RA(-) CCR7(-) CD4(+) T cells. CD4(+) T cells producing IFN-gamma are CD62L(-), and CD4(+) T cells producing IL-10 are CD62L(+), indicating that these cells have different tissue-homing capacities. These findings show that SLA and LACK induce both type 1 (IFN-gamma) and type 2 (IL-10 or IL-13) cell responses.
引用
收藏
页码:3122 / 3129
页数:8
相关论文
共 25 条
  • [1] Functional diversity of helper T lymphocytes
    Abbas, AK
    Murphy, KM
    Sher, A
    [J]. NATURE, 1996, 383 (6603) : 787 - 793
  • [2] A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity
    Belkaid, Y
    Mendez, S
    Lira, R
    Kadambi, N
    Milon, G
    Sacks, D
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (02) : 969 - 977
  • [3] Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble leishmania antigen in human cutaneous leishmaniasis
    Bottrel, RLA
    Dutra, WO
    Martins, FA
    Gontijo, B
    Carvalho, E
    Barral-Netto, M
    Barral, A
    Almeida, RP
    Mayrink, W
    Locksley, R
    Gollob, KJ
    [J]. INFECTION AND IMMUNITY, 2001, 69 (05) : 3232 - 3239
  • [4] Bourreau E, 2002, EUR J IMMUNOL, V32, P510, DOI 10.1002/1521-4141(200202)32:2<510::AID-IMMU510>3.0.CO
  • [5] 2-4
  • [6] Unresponsiveness of specific T cells to IL-12 is associated with active cutaneous leishmaniasis owing to Leishmania guyanensis
    Bourreau, E
    Prévot, G
    Pradinaud, R
    Launois, P
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2001, 54 (03) : 335 - 339
  • [7] Interleukin (IL)-13 is the predominant th2 cytokine in localized cutaneous leishmaniasis lesions and renders specific CD4+ T cells unresponsive to IL-12
    Bourreau, E
    Prévot, G
    Pradinaud, R
    Launois, P
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (06) : 953 - 959
  • [8] Lymphocyte homing and homeostasis
    Butcher, EC
    Picker, LJ
    [J]. SCIENCE, 1996, 272 (5258) : 60 - 66
  • [9] LEISHMANIA-REACTIVE CD4+ AND CD8+ T-CELLS ASSOCIATED WITH CURE OF HUMAN CUTANEOUS LEISHMANIASIS
    DACRUZ, AM
    CONCEICAOSILVA, F
    BERTHO, AL
    COUTINHO, SG
    [J]. INFECTION AND IMMUNITY, 1994, 62 (06) : 2614 - 2618
  • [10] CELL-POPULATIONS IN THE LESION OF HUMAN CUTANEOUS LEISHMANIASIS - A LIGHT MICROSCOPIC, IMMUNOHISTOCHEMICAL AND ULTRASTRUCTURAL-STUDY
    ESTERRE, P
    DEDET, JP
    FRENAY, C
    CHEVALLIER, M
    GRIMAUD, JA
    [J]. VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1992, 421 (03) : 239 - 247